1. A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide. (16th November 2020) Authors: Nakamura, Yusuke; Takemasa, Akihiro; Kushima, Yoshitomo; Soda, Sayo; Ikeda, Naoya; Arai, Ryo; Chibana, Kazuyuki; Nakazato, Yoshimasa; Yokose, Tomoyuki; Shimizu, Yasuo; Niho, Seiji Journal: Journal of chemotherapy Issue: Volume 32:Number 8(2020) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide. (16th November 2020) Authors: Nakamura, Yusuke; Takemasa, Akihiro; Kushima, Yoshitomo; Soda, Sayo; Ikeda, Naoya; Arai, Ryo; Chibana, Kazuyuki; Nakazato, Yoshimasa; Yokose, Tomoyuki; Shimizu, Yasuo; Niho, Seiji Journal: Journal of chemotherapy Issue: Volume 32:Number 8(2020) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide. (16th November 2020) Authors: Nakamura, Yusuke; Takemasa, Akihiro; Kushima, Yoshitomo; Soda, Sayo; Ikeda, Naoya; Arai, Ryo; Chibana, Kazuyuki; Nakazato, Yoshimasa; Yokose, Tomoyuki; Shimizu, Yasuo; Niho, Seiji Journal: Journal of chemotherapy Issue: Volume 32:Number 8(2020) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Carboplatin plus nab‐paclitaxel for recurrent small cell lung cancer: A phase II study. Issue 9 (22nd March 2022) Authors: Ikeda, Naoya; Arai, Ryo; Soda, Sayo; Inoue, Takashi; Uchida, Nobuhiko; Nakamura, Yusuke; Masawa, Meitetsu; Kushima, Yoshitomo; Okutomi, Hiroaki; Takemasa, Akihiro; Shimizu, Yasuo; Niho, Seiji Journal: Thoracic cancer Issue: Volume 13:Issue 9(2022) Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer. (11th April 2018) Authors: Arai, Ryo; Soda, Sayo; Okutomi, Tomoko; Morita, Hiroko; Ohmi, Fumito; Funakoshi, Tomoe; Takemasa, Akihiro; Ishii, Yoshiki Other Names: Chen Guobing Academic Editor. Journal: Journal of immunology research Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Osimertinib, a third‐generation EGFR tyrosine kinase inhibitor: A retrospective multicenter study of its real‐world efficacy and safety in advanced/recurrent non‐small cell lung carcinoma. Issue 4 (4th March 2020) Authors: Kishikawa, Takayuki; Kasai, Takashi; Okada, Masahiko; Nakachi, Ichiro; Soda, Sayo; Arai, Ryo; Takigami, Ayako; Sata, Masafumi Journal: Thoracic cancer Issue: Volume 11:Issue 4(2020) Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study. (23rd March 2018) Authors: Ko, Ryo; Shukuya, Takehito; Okuma, Yusuke; Tateishi, Kazunari; Imai, Hisao; Iwasawa, Shunichiro; Miyauchi, Eisaku; Fujiwara, Akiko; Sugiyama, Tomohide; Azuma, Keisuke; Muraki, Keiko; Yamasaki, Masahiro; Tanaka, Hisashi; Takashima, Yuta; Soda, Sayo; Ishimoto, Osamu; Koyama, Nobuyuki; Morita, Satos... Journal: Oncologist Issue: Volume 23:Number 10(2018) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗